Stockscreener 앱 받기
9.12
2.93%
0.26
시간 외 거래:
9.12
Embecta Corp 주식(EMBC)의 최신 뉴스
EmbectaAn Interesting Deal At An Interesting Time (NASDAQ:EMBC) - Seeking Alpha
Embecta to buy auto-injector maker Owen Mumford for $200M to diversify beyond insulin - Fierce Biotech
Embecta to acquire auto-injector maker Owen Mumford for up to $199.4M - Drug Delivery Business
Embecta to buy Owen Mumford for up to $201M - MedTech Dive
Embecta rallies after UK firm deal worth $200 million - MSN
Embecta to acquire UK medical device maker Owen Mumford for $200M - NJBIZ
Embecta (NASDAQ:EMBC) Trading 4.5% HigherTime to Buy? - MarketBeat
Embecta to Acquire Owen Mumford for up to $199.4M - Medical Product Outsourcing
Embecta acquires Owen Mumford for £150M - BioWorld MedTech
Embecta’s $133M Acquisition of Owen Mumford Marks a Turning Point - Medical Device and Diagnostic industry
Embecta Rallies After UK Firm Deal Worth $200 Million - Benzinga
Embecta to buy Owen Mumford for up to £150M - MSN
BTIG reiterates Embecta stock Buy rating on Owen Mumford deal - Investing.com
Embecta Corp. Stock Plummets to New 52-Week Low of $8.74 - Markets Mojo
Embecta announces definitive agreement to acquire Owen Mumford Holdings Limited - marketscreener.com
Embecta to acquire Owen Mumford for up to £150 million - Investing.com
Embecta’s Purchase of Owen Mumford Establishes Q3 2026 as a Key Driver for Surpassing Earnings Expectations and Strategic Valuation Shift - Bitget
Embecta bets up to £150M to expand from diabetes care into drug delivery - Stock Titan
Embecta (NASDAQ:EMBC) Reaches New 1-Year LowShould You Sell? - MarketBeat
Embecta Corp. (NASDAQ:EMBC) Sees Large Increase in Short Interest - MarketBeat
BTIG Lowers PT on Embecta Corp. (EMBC) to $25, Keeps a Buy Rating - MSN
The Technical Signals Behind (EMBC) That Institutions Follow - Stock Traders Daily
Embecta Corp. Stock Plummets to New 52-Week Low of $9.06 - Markets Mojo
Embecta Corp. Stock Plummets to New 52-Week Low of $8.81 - Markets Mojo
Embecta (NASDAQ:EMBC) Hits New 1-Year LowHere's What Happened - MarketBeat
NanoTess lands Embecta deal to put its tech in 14,000 Canadian pharmacies - BetaKit
Embecta Stock Pre-Market (+6.5%): Enters Wound Care Market with Canadian Distribution Deal - Trefis
Calgary Startup NanoTess Signs Deal with Diabetes Care Leader embecta to Bring Catalytic Wound Care to All Canadians - Yahoo Finance
Jefferies Financial Group Inc. Boosts Stock Position in Embecta Corp. $EMBC - MarketBeat
Embecta (NASDAQ:EMBC) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Technical Analysis: Can Embecta Corp withstand a market correctionJuly 2025 Institutional & Weekly Top Gainers Trade List - baoquankhu1.vn
Embecta (NASDAQ:EMBC) Sets New 52-Week LowHere's What Happened - MarketBeat
EMBC SEC FilingsEmbecta Corp 10-K, 10-Q, 8-K Forms - Stock Titan
William Blair Investment Management LLC Sells 312,857 Shares of Embecta Corp. $EMBC - MarketBeat
Precision Trading with Embecta Corp. (EMBC) Risk Zones - Stock Traders Daily
InvestingPro’s Fair Value spotted Embecta overvaluation before 47% drop By Investing.com - Investing.com South Africa
EMBCEmbecta Corp Latest Stock News & Market Updates - Stock Titan
Embecta Corp. (EMBC) Stock Analysis: Attractive Dividend Yield and Significant Upside Potential Beckon Investors - DirectorsTalk Interviews
EMBC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Aug Drivers: Why is Embecta Corp stock going upWeekly Volume Report & Risk Controlled Daily Trade Plans - baoquankhu1.vn
BTIG Keeps Their Buy Rating on Embecta Corporation (EMBC) - The Globe and Mail
Embecta Corp. (EMBC) Stock Analysis: A 58.28% Potential Upside In Medical Device Innovation - DirectorsTalk Interviews
Public Sector Pension Investment Board Increases Stock Position in Embecta Corp. $EMBC - MarketBeat
Technical Reactions to EMBC Trends in Macro Strategies - Stock Traders Daily
Does Embecta Corp. have high return on assets2025 Volatility Report & Safe Swing Trade Setup Alerts - mfd.ru
Embecta shareholders back board, pay, and equity plan - The Globe and Mail
Will Embecta Corp. stock gain from lower inflationPortfolio Performance Report & High Conviction Buy Zone Alerts - mfd.ru
Why analysts remain bullish on Embecta Corp. stockPortfolio Return Summary & Reliable Price Breakout Signals - mfd.ru
Embecta's (NASDAQ:EMBC) Solid Earnings Have Been Accounted For Conservatively - simplywall.st
Why Embecta's (NASDAQ:EMBC) Earnings Are Better Than They Seem - 富途牛牛
We Think Embecta's (NASDAQ:EMBC) Solid Earnings Are Understated - Yahoo Finance
Embecta names CEO Kurdikar as new board chair, picks new lead independent director - Drug Delivery Business
Embecta Corp. Appoints Devdatt Kurdikar as Chairman and Dr. Claire Pomeroy as Lead Independent Director - Quiver Quantitative
embecta names new Chairman of the Board and Lead Independent Director - The Manila Times
What’s the RSI of Embecta Corp. stock2025 Trade Ideas & AI Forecasted Entry and Exit Points - mfd.ru
Embecta (NASDAQ:EMBC) Is Paying Out A Dividend Of $0.15 - Yahoo Finance
Embecta outlines $1.71B–$1.93B revenue target for 2026 as GLP-1 partnerships gain traction - MSN
Can Embecta Corp. stock surprise with earnings upside2025 Stock Rankings & Low Risk High Reward Trade Ideas - mfd.ru
0.06%
0.65%
자본화:
|
볼륨(24시간):